The Biosero Acceleration Lab in San Diego, CA, opened its doors to executives, managers, researchers, and automation engineers to showcase its flagship Green Button Go Automation Scheduling Software.
On Dec. 10, 2019, the Biosero Acceleration Lab in San Diego, CA, opened its doors to executives, managers, researchers, and automation engineers to showcase its flagship Green Button Go Automation Scheduling Software with the help of a Rockwell Automation OMRON LD90 mobile robot.
According to a company press release, upon arriving, visitors were greeted by the mobile robot who escorted them to the lab and introduced the range of processes and applications the software suite brings to the automation lab, including:
“The Acceleration Lab proves that total lab automation is possible-now. Right before your eyes, you’ll see that Green Button Go software can command everything in a lab-from a mobile robot, to a robotic arm, to a plate reader,” said Biosero CEO Tom Gilman in the press release. “Researchers and engineers marvel at the software’s capability to connect equipment from different OEMs [original equipment manufacturers] and completely automate their processes. The most impressive component is that everything is integrated, including manual tasks, and all data is collected for analysis.”
Group tours of the Biosero Acceleration Lab can be scheduled for Jan. 29, 2020 from 4 pm to 6 pm during the Society for Laboratory Automation and Screening 2020 event.
Source: Biosero
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.